Thinking of Future.png

HEARTBREAK IS…

mourning THE LOSS OF someone while they are still alive


Many of us know someone with Alzheimer’s disease, the most common form of dementia. Over $30 billion has been spent to develop a drug-based cure for it. So far, nothing works.

We are determined to end Alzheimer's disease with Arethusta®, a first-in-class outpatient treatment. Our first mission is to test it by reversing mild cognitive impairment associated with Alzheimer’s disease. Afterward, we intend to use Arethusta to prevent and cure Alzheimer’s itself. Our work is attracting significant attention.

 

The science 

The facts 


HELP US FIGHT ALZHEIMER’S DISEASE

There is still time to enroll in our 2,000-person clinical study to assess risk of Alzheimer’s disease.

 
 
 

Project Cribrose will help us refine our proprietary diagnostic tools to more precisely determine the likelihood of a patient developing Alzheimer’s disease. Participants will sit for a 20-second CT scan and undergo a battery of cognitive tests developed by Leucadia Therapeutics. Project Cribrose is a collaboration with neurosurgeons at Arrowhead Regional Medical Center in Colton, California.